choline has been researched along with pioglitazone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horsmans, Y; Leclercq, IA; Sempoux, C; Stärkel, P | 1 |
| Akahori, H; Kaneko, S; Kita, Y; Kurita, S; Matsuzawa, N; Misu, H; Nakanuma, Y; Ota, T; Sakurai, M; Takamura, T; Uno, M; Zen, Y | 1 |
| Du, J; Kong, L; Nan, Y; Niu, X; Wang, R; Zhang, Y; Zhao, S | 1 |
| Arora, G; Baumert, TF; Erstad, DJ; Fuchs, BC; Ghoshal, S; Hoshida, Y; Lanuti, M; Li, S; Masia, R; Sojoodi, M; Tanabe, KK | 1 |
4 other study(ies) available for choline and pioglitazone
| Article | Year |
|---|---|
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats.
Topics: Animals; Bile Ducts; Carbon Tetrachloride; Choline; Collagen Type I; Disease Progression; Hypoglycemic Agents; Ligation; Liver Cirrhosis, Experimental; Male; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazolidinediones; Time Factors; Treatment Outcome | 2006 |
Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Topics: Animal Feed; Animals; Choline; Collagen Type I; Collagen Type I, alpha 1 Chain; Diabetes Mellitus, Type 2; Dietary Fats; Disease Models, Animal; Fatty Liver; Hyperinsulinism; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Methionine; Obesity; Pioglitazone; Plasminogen Activator Inhibitor 1; PPAR gamma; Rats; Rats, Inbred OLETF; Rats, Long-Evans; RNA, Messenger; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones; Transforming Growth Factor beta; Up-Regulation | 2007 |
TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice.
Topics: Animals; Chemokines; Choline; Diet; Down-Regulation; Fibrosis; Inflammation; Liver; Liver Cirrhosis; Male; Methionine; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Pioglitazone; PPAR gamma; Protective Agents; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2016 |
Pioglitazone Reduces Hepatocellular Carcinoma Development in Two Rodent Models of Cirrhosis.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Carcinoma, Hepatocellular; Choline; Diet, High-Fat; Diethylnitrosamine; Disease Models, Animal; Disease Progression; Hypoglycemic Agents; Liver Cirrhosis; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Pioglitazone; Rats; Rats, Wistar; Signal Transduction | 2019 |